• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从印度尼西亚的 COVID-19 疫苗接种中吸取的经验教训:经验、挑战和机遇。

Lessons learned from COVID-19 vaccination in Indonesia: experiences, challenges, and opportunities.

机构信息

Ministry of Finance Republic of Indonesia.

Prasetiya Mulya University.

出版信息

Hum Vaccin Immunother. 2021 Nov 2;17(11):3898-3906. doi: 10.1080/21645515.2021.1975450. Epub 2021 Oct 6.

DOI:10.1080/21645515.2021.1975450
PMID:34613879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8828161/
Abstract

The development of safe and effective COVID-19 vaccines as well as their delivery to people's arms are the best hope for ending the COVID-19 pandemic. However, the implementation of vaccination varies greatly across countries, with the developing countries lagging behind. This study investigates Indonesia's vaccination experiences, challenges, and acceleration over the course of implementation period. This study provides simulations to estimate the vaccination rate using time-series forecasting machine learning. We use Administrative data and Survey results in our analysis. Our findings suggest limited vaccine availability had caused low-coverage vaccination implementation in the early stage of vaccination implementation period. However, following the increased availability of vaccine, the vaccination rate accelerates up to 600% times. The government of Indonesia utilized strategic public places, public and private offices, and engaging private sectors in the phase two implementation to accelerate the vaccination implementation. Indonesia might reach 63.1 million individuals vaccinated at the end of March 2022, or 35% of the targeted population with up to April 2021 vaccination rate. To accelerate, government introduced a number of new strategies including door-to-door persuasion through neighborhood association (RT), educating individuals, and providing transportation from their home to the vaccination facility. We expect new strategies could further improve vaccination speed by around 1.4 million to 3.5 million individuals per day.

摘要

开发安全有效的 COVID-19 疫苗并将其送到人们的手中是结束 COVID-19 大流行的最佳希望。然而,各国在疫苗接种的实施方面存在很大差异,发展中国家较为落后。本研究调查了印度尼西亚在实施期间的疫苗接种经验、挑战和加速情况。本研究提供了使用时间序列预测机器学习来估计疫苗接种率的模拟。我们在分析中使用了行政数据和调查结果。我们的研究结果表明,疫苗供应有限导致疫苗接种实施初期的接种率较低。然而,随着疫苗供应量的增加,疫苗接种率加速至原来的 600%倍。印度尼西亚政府在实施的第二阶段利用战略公共场所、公共和私人办公室以及私营部门来加速疫苗接种的实施。到 2022 年 3 月底,印度尼西亚可能会有 6310 万人接种疫苗,或者按照 2021 年 4 月的疫苗接种率,达到目标人口的 35%。为了加速疫苗接种,政府引入了一些新策略,包括通过邻里协会(RT)挨家挨户进行劝说、教育个人以及提供从家中到接种点的交通服务。我们预计新策略每天可以将疫苗接种速度提高 140 万至 350 万人。

相似文献

1
Lessons learned from COVID-19 vaccination in Indonesia: experiences, challenges, and opportunities.从印度尼西亚的 COVID-19 疫苗接种中吸取的经验教训:经验、挑战和机遇。
Hum Vaccin Immunother. 2021 Nov 2;17(11):3898-3906. doi: 10.1080/21645515.2021.1975450. Epub 2021 Oct 6.
2
From Archipelago to Pandemic Battleground: Unveiling Indonesia's COVID-19 Crisis.从群岛到抗疫战场:揭开印尼的新冠危机。
J Epidemiol Glob Health. 2023 Dec;13(4):591-603. doi: 10.1007/s44197-023-00148-7. Epub 2023 Sep 14.
3
Offering onsite COVID-19 vaccination to high-risk obstetrical patients: initial findings.为高危产科患者提供现场 COVID-19 疫苗接种:初步发现。
Am J Obstet Gynecol MFM. 2021 Nov;3(6):100478. doi: 10.1016/j.ajogmf.2021.100478. Epub 2021 Sep 2.
4
The First Intra-Action Review of Indonesia's Response to the COVID-19 Pandemic, August 2020.2020 年 8 月,印度尼西亚对 COVID-19 大流行反应的首次行动审查。
Health Secur. 2021 Sep-Oct;19(5):521-531. doi: 10.1089/hs.2021.0071. Epub 2021 Sep 27.
5
Hashtag as a new weapon to resist the COVID-19 vaccination policy: a qualitative study of the anti-vaccine movement in Brazil, USA, and Indonesia.标签作为抵制 COVID-19 疫苗接种政策的新武器:对巴西、美国和印度尼西亚反疫苗运动的定性研究。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2042135. doi: 10.1080/21645515.2022.2042135. Epub 2022 Mar 3.
6
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
7
COVID-19 vaccine prioritization based on district classification in Yogyakarta Province, Indonesia.印度尼西亚日惹特区基于地区分类的 COVID-19 疫苗优先接种。
Geospat Health. 2022 Jan 14;17(s1). doi: 10.4081/gh.2022.1010.
8
The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.在英国和美国,针对成年人的 COVID-19 疫苗副作用风险的描述和沟通对疫苗接种意愿的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Sep 6;22(1):592. doi: 10.1186/s13063-021-05484-2.
9
Indonesian nursing students' intention to accept COVID-19 vaccines: an online, multicentre survey.印度尼西亚护理专业学生接种 COVID-19 疫苗的意愿:一项在线、多中心调查。
Br J Nurs. 2022 May 12;31(9):488-494. doi: 10.12968/bjon.2022.31.9.488.
10
Bhutan's COVID-19 Vaccination Efforts and the Evolution of COVID-19 Cases in the Aftermath.不丹的 COVID-19 疫苗接种工作及 COVID-19 病例在疫情后的演变。
Asia Pac J Public Health. 2022 Jan;34(1):125-127. doi: 10.1177/10105395211052178. Epub 2021 Oct 21.

引用本文的文献

1
Association between vaccination uptake, vaccine type, and long COVID in rural Indonesia.印度尼西亚农村地区疫苗接种率、疫苗类型与长期新冠症状之间的关联
Front Public Health. 2025 Jul 28;13:1598246. doi: 10.3389/fpubh.2025.1598246. eCollection 2025.
2
Tracking the financial flows of Indonesia's COVID-19 vaccination program.追踪印度尼西亚新冠疫苗接种计划的资金流向。
PLOS Glob Public Health. 2025 Aug 5;5(8):e0005041. doi: 10.1371/journal.pgph.0005041. eCollection 2025.
3
Post COVID-19 vaccination binding and neutralizing antibody with or without previous infection: An 18-month longitudinal study in Indonesia.新冠病毒疫苗接种后有无既往感染情况下的结合抗体和中和抗体:印度尼西亚一项为期18个月的纵向研究
Narra J. 2024 Aug;4(2):e1071. doi: 10.52225/narra.v4i2.1071. Epub 2024 Aug 31.
4
Hospital services utilisation and cost before and after COVID-19 hospital treatment: Evidence from Indonesia.新冠肺炎治疗前后医院服务利用和费用:来自印度尼西亚的证据。
PLoS One. 2024 Jul 5;19(7):e0305835. doi: 10.1371/journal.pone.0305835. eCollection 2024.
5
Essential healthcare services during the COVID-19 pandemic: a cross-sectional study of community needs and perspectives in West Java, Indonesia.在 COVID-19 大流行期间的基本医疗服务:对印度尼西亚西爪哇社区需求和观点的横断面研究。
BMJ Open. 2024 Jan 22;14(1):e077585. doi: 10.1136/bmjopen-2023-077585.
6
SARS-CoV-2 IgG antibody status in unvaccinated and 2-dose vaccinated Indonesians by AstraZeneca.未接种疫苗以及接种两剂阿斯利康疫苗的印度尼西亚人新冠病毒2型免疫球蛋白G抗体状态
J Public Health Afr. 2023 Dec 1;14(12):2697. doi: 10.4081/jphia.2023.2697. eCollection 2023 Dec 27.
7
From Archipelago to Pandemic Battleground: Unveiling Indonesia's COVID-19 Crisis.从群岛到抗疫战场:揭开印尼的新冠危机。
J Epidemiol Glob Health. 2023 Dec;13(4):591-603. doi: 10.1007/s44197-023-00148-7. Epub 2023 Sep 14.
8
Assessing the user satisfaction on COVID-19 vaccination service in Indonesia.评估印度尼西亚民众对新冠疫苗接种服务的满意度。
J Public Health Res. 2023 Jun 21;12(2):22799036231181852. doi: 10.1177/22799036231181852. eCollection 2023 Apr.
9
The use of Health Belief Model (HBM) to explain factors underlying people to take the COVID-19 vaccine in Indonesia.运用健康信念模型(HBM)来解释印度尼西亚民众接种新冠疫苗背后的因素。
Vaccine X. 2023 Aug;14:100297. doi: 10.1016/j.jvacx.2023.100297. Epub 2023 Apr 8.
10
Urip iku urup (life is lit) by service to others: a qualitative study of frontline healthcare workers' lived experiences providing patient care in Indonesia's COVID-19-designated hospital.服务他人即人生意义:印度尼西亚新冠定点医院一线医护人员提供病患照护的生活体验定性研究
BMC Health Serv Res. 2023 Mar 16;23(1):262. doi: 10.1186/s12913-023-09257-2.

本文引用的文献

1
COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room.新冠病毒疫苗的效力和效果——房间里的(并非)大象。
Lancet Microbe. 2021 Jul;2(7):e279-e280. doi: 10.1016/S2666-5247(21)00069-0. Epub 2021 Apr 20.
2
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.确保全球公平获得 COVID-19 疫苗面临的挑战:生产、可负担性、分配和部署。
Lancet. 2021 Mar 13;397(10278):1023-1034. doi: 10.1016/S0140-6736(21)00306-8. Epub 2021 Feb 12.
3
AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal.用于新冠肺炎的阿斯利康新冠疫苗(Covishield):尼泊尔的经验、挑战与解决方案
Travel Med Infect Dis. 2021 Mar-Apr;40:101989. doi: 10.1016/j.tmaid.2021.101989. Epub 2021 Feb 10.
4
Development and deployment of COVID-19 vaccines for those most vulnerable.为最脆弱人群开发和部署 COVID-19 疫苗。
Sci Transl Med. 2021 Feb 3;13(579). doi: 10.1126/scitranslmed.abd1525.
5
The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States.疫苗接种对美国 2019 年冠状病毒病(COVID-19)疫情爆发的影响。
Clin Infect Dis. 2021 Dec 16;73(12):2257-2264. doi: 10.1093/cid/ciab079.
6
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.一项在 18-59 岁健康成年人中进行的新型冠状病毒灭活疫苗的安全性、耐受性和免疫原性的随机、双盲、安慰剂对照、1/2 期临床试验。
Lancet Infect Dis. 2021 Feb;21(2):181-192. doi: 10.1016/S1473-3099(20)30843-4. Epub 2020 Nov 17.
7
Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia.东南亚民众对 COVID-19 疫苗的接受程度:印度尼西亚的一项横断面研究。
Front Public Health. 2020 Jul 14;8:381. doi: 10.3389/fpubh.2020.00381. eCollection 2020.
8
COVID-19: Mechanisms of Vaccination and Immunity.新冠病毒:疫苗接种与免疫机制
Vaccines (Basel). 2020 Jul 22;8(3):404. doi: 10.3390/vaccines8030404.
9
Challenges and Barriers to Providing Care to Older Adult Patients in the Intensive Care Unit: A Qualitative Research.重症监护病房为老年患者提供护理的挑战与障碍:一项定性研究
Open Access Maced J Med Sci. 2019 Oct 13;7(21):3682-3690. doi: 10.3889/oamjms.2019.846. eCollection 2019 Nov 15.
10
Interventions to increase the distribution of vaccines in Sub-Saharan Africa: a scoping review.增加撒哈拉以南非洲地区疫苗分发的干预措施:一项范围综述。
Pan Afr Med J. 2019 Jan 9;32:14. doi: 10.11604/pamj.2019.32.14.17225. eCollection 2019.